Home
| Log in or Sign Up for full access
| Tracked Organizations
| Recent Tracked Activities
Recent Activities
Activities between Nov. 15, 2024, 7:50 p.m. and Nov. 22, 2024, 7:50 p.m.
from: Regenerative Medicine Services.
Click on a document link to see the original source document.
Click on the name of an organization to see more organization linkages and timelines.
Document Date: Nov. 20, 2024, 1:30 p.m. / Source: GlobeNewswire
Activity Class: PartnershipActivity
/ Region: Provinsi Bali
Partnership:
Document Extract: FLORHAM PARK, N.J., Nov. 20, 2024 (GLOBE NEWSWIRE) - Celularity Inc. (Nasdaq: CELU) ("Celularity") , a regenerative and cellular medicine company, today announced that its strategic partner, Genting Berhad, has broken ground on Fontaine Vitale, a state-of-the-art stem cell and regenerative medicine facility in the Sanur Special Economic Zone located in Bali, Indonesia. Fontaine Vitale will offer world-class cell therapies focused on wellness, aesthetics, and regenerative medicine to both local and international patients using placenta-derived stem cells manufactured by Celularity in its US facility, according to Genting Berhad's press release. The new center is expected to commence commercial operations towards the end of 2026. As disclosed by Genting Berhad, Celularity will manufacture stem cells for export and use at the Sanur Special Economic Zone facility at Celularity's 150,000sf cGMP research and manufacturing center located in Florham Park, NJ. Longer term, Genting Berhad and Celularity expect to initiate onsite manufacturing operations in the Sanur Special Economic Zone under Celularity's technical supervision.
Document Source: https://www.globenewswire.com/news-release/2024/11/20/2984440/0/en/Celularity-s-Strategic-Partner-Announces-Groundbreaking-for-State-of-the-Art-Stem-Cell-Regenerative-Medicine-Center-in-Asia-Pacific.html
(archive.org page /
archive.org listing)
Archive.org page links will work if the page has already been archived by archive.org, but we can't guarantee which pages archive.org has archived so far.
Treat sameAsNameOnly relationship as same? Yes
(Turn Off)
Site Stats
| About (includes privacy and cookie notices)
(c) by 1145, 2023-2024. Data licensed under the Open Database License.
Please send an email if you need a non-share-alike license and/or you need API access.